GlassScriptPhysician profile
Christopher D Geiger
NPI 1043576390
$1,105.48
in general payments reported to CMS, 2019-2025
19 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $35.08 · 2022: $135 · 2023: $256 · 2024: $248 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $230.30 | 2019-2025 | Ultomiris |
| Amgen INC. | $126.32 | 2019-2025 | Uplizna |
| Argenx US, INC. | $106.69 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Horizon Therapeutics Plc | $96.47 | 2022-2023 | Uplizna |
| Ucb, INC. | $82.25 | 2024 | Zilbrysq |
| Lilly USA, LLC | $63.23 | 2023-2025 | Amyvid, Kisunla, Emgality |
| Genzyme Corporation | $61.71 | 2022 | |
| Averitas Pharma INC. | $49.77 | 2023-2025 | Qutenza |
| Alnylam Pharmaceuticals INC. | $41.45 | 2025 | Onpattro |
| Tg Therapeutics, INC. | $40.40 | 2024-2025 | |
| Lundbeck LLC | $39.23 | 2019-2020 | |
| Tanabe Pharma America, INC. | $31.07 | 2019 | |
| Csl Behring | $27.88 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.60 | 2024 | Hyqvia |
| Biogen, INC. | $20.09 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $17.99 | 2025 | Austedo Xr |
| Grifols USA, LLC | $17.11 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.67 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Geiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.